| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |